University of California·California

UCI-RFP-26PTK012 UCI Cognic-E Nutraceutical Drug Development for Alzheimer’s

Closes 10/9/2026

Bid source

Description

Click the "Link to bid" button below for more information

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+

bids & awards

All 50

states

4,000+

agencies

Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

Learn more

California guideCalifornia Bids and Bidding Guide
Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide

More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →

Description

Attached files

Similar opportunities

You found this one too late. Don't find the next one too late.

Learn more

Description

Attached files

Similar opportunities

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)

Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

Data Coordinating Center for the Aging and Alzheimer?s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)

NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 Independent Clinical Trial Not Allowed)

Alzheimer's Disease Programs Initiative (ADPI) - Developing Dementia-Capable Community Health Worker Programs in the National Aging Network

Alzheimer's Disease Programs Initiative (ADPI) - States and Community Grants (Winter 2025)

Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 Independent Clinical Trial Not Allowed)

BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)

Single Source: Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Data Resource and Administrative Coordination Center (U24 Clinical Trial Not Allowed)

Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)

Multimodal AI to Accelerate Precision Medicine for Type 1 Diabetes (U01- Clinical Trials Not Allowed)

Cognitive Neuroscience (CogNeuro)

NIDA Avenir Program: Fundamental Mechanistic Research in Addiction Science

Functional Target Validation for Alzheimer's Disease-Related Dementias

Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required

Studies Addressing Rare Neurodegenerative Diseases including ALS

BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iBCP (RM1 Clinical Trial Not Allowed)

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development

Continuation of the Exceptional Longevity Data Management and Coordinating Center (EL DMCC) (U24 Clinical Trial Not Allowed)

The NIA Genetics of Alzheimer's Disease Data Storage Site (NIAGADS)

BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System

You found this one too late. Don't find the next one too late.

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)

Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

Data Coordinating Center for the Aging and Alzheimer?s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)

NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 Independent Clinical Trial Not Allowed)

Alzheimer's Disease Programs Initiative (ADPI) - Developing Dementia-Capable Community Health Worker Programs in the National Aging Network

Alzheimer's Disease Programs Initiative (ADPI) - States and Community Grants (Winter 2025)

Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 Independent Clinical Trial Not Allowed)

BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)

Single Source: Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Data Resource and Administrative Coordination Center (U24 Clinical Trial Not Allowed)

Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)

Multimodal AI to Accelerate Precision Medicine for Type 1 Diabetes (U01- Clinical Trials Not Allowed)

Cognitive Neuroscience (CogNeuro)

NIDA Avenir Program: Fundamental Mechanistic Research in Addiction Science

Functional Target Validation for Alzheimer's Disease-Related Dementias

Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required

Studies Addressing Rare Neurodegenerative Diseases including ALS

BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iBCP (RM1 Clinical Trial Not Allowed)

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development

Continuation of the Exceptional Longevity Data Management and Coordinating Center (EL DMCC) (U24 Clinical Trial Not Allowed)

The NIA Genetics of Alzheimer's Disease Data Storage Site (NIAGADS)

BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System